KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EBT (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -61.06%
Dec 31, 2025 273.67%
Sep 30, 2025 -54.05%
Jun 30, 2025 -6.44%
Mar 31, 2025 173.20%
Dec 31, 2024 -208.88%
Sep 30, 2024 -2.89%
Jun 30, 2024 22.28%
Mar 31, 2024 44.80%
Dec 31, 2023 -37.94%
Sep 30, 2023 -25.17%
Jun 30, 2023 449.47%
Mar 31, 2023 -83.98%
Dec 31, 2022 -32.61%
Sep 30, 2022 271.94%
Jun 30, 2022 -76.00%
Mar 31, 2022 15.41%
Dec 31, 2021 15.81%
Sep 30, 2021 217.11%
Jun 30, 2021 -69.93%
Mar 31, 2021 356.60%
Dec 31, 2020 -160.28%
Sep 30, 2020 460.75%
Jun 30, 2020 -122.37%
Mar 31, 2020 0.78%
Dec 31, 2019 53.62%
Sep 30, 2019 147.96%
Jun 30, 2019 -68.28%
Mar 31, 2019 207.21%
Dec 31, 2018 -185.95%
Sep 30, 2018 37.23%
Jun 30, 2018 -28.07%
Mar 31, 2018 134.45%
Dec 31, 2017 -43.05%
Sep 30, 2017 -10.96%
Jun 30, 2017 12.80%
Mar 31, 2017 4.40%
Dec 31, 2016 -0.79%
Sep 30, 2016 -3.91%
Jun 30, 2016 18.02%
Mar 31, 2016 -7.69%
Dec 31, 2015 16.82%
Sep 30, 2015 -1.85%
Jun 30, 2015 20.20%
Mar 31, 2015 234.62%
Dec 31, 2014 -250.95%
Sep 30, 2014 -52.06%
Jun 30, 2014 11.43%
Mar 31, 2014 -10.63%
Dec 31, 2013 11.90%
Sep 30, 2013 -5.99%
Jun 30, 2013 10.41%
Mar 31, 2013 -27.67%
Dec 31, 2012 6.80%
Sep 30, 2012 14.41%
Jun 30, 2012 39.36%